About this trial
The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device.
In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum.
Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.
Eligibility criteria
Qualifiers
Spontaneous vaginal delivery within the last 4-8 weeks
Age ≥ 18 years
Ambulatory
Willing and able to consent to participate.
Disqualifiers
Operative or cesarean delivery
Obstetric delivery at less than 20 weeks gestation
Third- or fourth-degree perineal laceration
Episiotomy
Trial design
Treatments tested in this trial
- Digital therapeutic motion-based device